CARPENTER TECHNOLOGY CORPORATION financials

  1. Home
  2. Financials
  3. CRS
CRS CIK 0000017843

Source: EDGAR filings · Built 2026-06-02T02:44:59Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 286.10M 178.30M -67.60M -85.30M 149.50M 60.40M
EBITDA 661.00M 457.70M 264.10M 106.50M -125.00M 149.20M
Working Capital 1.28B 1.12B 822.50M 743.80M 811.10M 814.20M
Net Debt 422.80M 542.30M 701.20M 590.20M 451.60M 590.50M
Gross Margin 26.71% 21.17% 13.23% 8.16% 0.07% 15.10%
Operating Margin 18.14% 11.71% 5.22% -1.36% -16.85% 1.16%
Net Margin 13.07% 6.76% 2.21% -2.67% -15.56% 0.07%
Return on Equity (ROE) 19.93% 11.45% 4.04% -3.69% -16.49% 0.10%
Return on Assets (ROA) 10.78% 5.67% 1.85% -1.67% -7.73% 0.05%
Current Ratio 3.65× 3.41× 2.79× 2.98× 3.65× 2.80×
Debt-to-Equity 0.39× 0.46× 0.53× 0.56× 0.53× 0.54×
Effective Tax Rate 19.54% 11.86% 22.21% 22.19% 22.93% 75.41%
Cash Conversion Ratio 1.17× 1.47× 0.26× -0.12× -1.09× 154.53×
Accruals Ratio -0.02× -0.03× 0.01× -0.02× -0.16× -0.07×
SBC % of Revenue 0.79% 0.72% 0.64% 0.59% 0.70% 0.50%
CapEx Coverage 2.85× 2.85× 0.18× 0.07× 2.49× 1.35×
Free Cash Flow Per Share $5.64 $3.54 $-1.37 $-1.76 $3.10 $1.25

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 37.25× 29.62× 49.24× — — 1214.00×
P/FCF 48.98× 30.91× — — 12.99× 19.38×
FCF Yield 2.04% 3.23% — — 7.70% 5.16%
EV / EBITDA 21.42× 13.10× 12.99× 18.20× — 11.74×
P/S 4.78× 1.98× 1.07× 0.73× 1.31× 0.53×
P/B 7.28× 3.35× 1.96× 1.01× 1.39× 0.80×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 2.88B 2.76B 2.55B 1.84B 1.48B 2.18B
Gross Profit 768.60M 584.30M 337.30M 149.80M 1.00M 329.40M
Research and Development Expense 26.10M 25.60M 24.40M 20.40M 19.70M 28.00M
Selling, General and Administrative Expense 243.20M 230.20M 204.20M 174.70M 180.20M 201.00M
Operating Income (Loss) 521.80M 323.10M 133.10M -24.90M -248.60M 25.30M
Income Tax Expense (Benefit) 91.30M 25.10M 16.10M -14.00M -68.30M 4.60M
Net Income (Loss) Attributable to Parent 376.00M 186.50M 56.40M -49.10M -229.60M 1.50M
Earnings Per Share, Basic $7.50 $3.75 $1.15 $-1.01 $-4.76 $0.02
Weighted Average Number of Shares Outstanding, Basic 50.20M 49.70M 48.80M 48.50M 48.30M 48.10M
Earnings Per Share, Diluted $7.42 $3.70 $1.14 $-1.01 $-4.76 $0.02
Weighted Average Number of Shares Outstanding, Diluted 50.70M 50.30M 49.20M 48.50M 48.30M 48.20M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 315.50M 199.10M 44.50M 154.20M 287.40M 193.10M
Assets, Current 1.76B 1.59B 1.28B 1.12B 1.12B 1.27B
Assets 3.49B 3.29B 3.05B 2.93B 2.97B 3.23B
Long-term Debt — — — 691.80M 694.50M 551.80M
Liabilities, Current 483.70M 466.30M 459.40M 375.60M 306.30M 452.10M
Long-term Debt, Excluding Current Maturities 695.40M 694.20M 693.00M 691.80M 694.50M 551.80M
Liabilities 1.60B 1.66B 1.66B 1.60B 1.58B 1.78B
Stockholders' Equity Attributable to Parent 1.89B 1.63B 1.40B 1.33B 1.39B 1.45B
Common Stock, Shares, Outstanding 49.71M 49.78M 48.64M 48.29M 48.04M 47.85M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 440.40M 274.90M 14.70M 6.00M 250.00M 231.80M
Net Cash Provided by (Used in) Investing Activities -152.90M -95.90M -82.30M -89.10M -78.90M -171.20M
Payments for Repurchase of Common Stock 101.90M 0 0 — — —
Payments of Dividends 40.30M 40.00M 39.40M 39.20M 39.10M 38.80M
Net Cash Provided by (Used in) Financing Activities -167.10M -23.30M -40.10M -52.80M -76.10M 107.80M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CRS CIK 0000017843), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

EVC

ENTRAVISION COMMUNICATIONS CORPORATION

OCUL

Ocular Therapeutix, Inc.

XERS

XERIS BIOPHARMA HOLDINGS, INC.